 | • レポートコード：MRC2312MG14652 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の万能細胞治療薬市場規模と予測を収録しています。・世界の万能細胞治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の万能細胞治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の万能細胞治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「細胞治療」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 万能細胞治療薬のグローバル主要企業は、Novartis、 Gilead Sciences、 Bluebird Bio、 Juno Therapeutics、 Spark Therapeutics、 Kite Pharma、 Celgene、 Regeneron Pharmaceuticals、 Adaptimmune、 CRISPR Therapeuticsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、万能細胞治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の万能細胞治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の万能細胞治療薬市場：タイプ別市場シェア、2022年 ・細胞治療、遺伝子治療、幹細胞治療 世界の万能細胞治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の万能細胞治療薬市場：用途別市場シェア、2022年 ・病院、研究所 世界の万能細胞治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の万能細胞治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における万能細胞治療薬のグローバル売上、2018年-2023年 ・主要企業における万能細胞治療薬のグローバル売上シェア、2022年 ・主要企業における万能細胞治療薬のグローバル販売量、2018年-2023年 ・主要企業における万能細胞治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novartis、 Gilead Sciences、 Bluebird Bio、 Juno Therapeutics、 Spark Therapeutics、 Kite Pharma、 Celgene、 Regeneron Pharmaceuticals、 Adaptimmune、 CRISPR Therapeutics ************************************************************* ・調査・分析レポートの概要 万能細胞治療薬市場の定義 市場セグメント 世界の万能細胞治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の万能細胞治療薬市場規模 世界の万能細胞治療薬市場規模：2022年 VS 2029年 世界の万能細胞治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの万能細胞治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の万能細胞治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：細胞治療、遺伝子治療、幹細胞治療 万能細胞治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、研究所 万能細胞治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別万能細胞治療薬市場規模 2022年と2029年 地域別万能細胞治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novartis、 Gilead Sciences、 Bluebird Bio、 Juno Therapeutics、 Spark Therapeutics、 Kite Pharma、 Celgene、 Regeneron Pharmaceuticals、 Adaptimmune、 CRISPR Therapeutics ... |
This research report provides a comprehensive analysis of the Universal Cell Therapy Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Universal Cell Therapy Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Universal Cell Therapy Drug, challenges faced by the industry, and potential opportunities for market players.
The global Universal Cell Therapy Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Universal Cell Therapy Drug market presents opportunities for various stakeholders, including Hospital, Research Center. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Universal Cell Therapy Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global Universal Cell Therapy Drug market was valued at US$ 338.6 million in 2022 and is projected to reach US$ 1050 million by 2029, at a CAGR of 17.7% during the forecast period.
Universal cell therapies are a revolutionary class of medicines that use biotechnology to modify a patient’s cells to treat a variety of diseases, including cancer, genetic disorders and autoimmune diseases. Increasingly, generic cell therapies will move toward personalized treatments to tailor treatment plans to each patient’s specific condition and genotype. Universal cell therapies continue to expand their indications to include the treatment of rare diseases, autoimmune diseases and other diseases. Universal cell therapy drugs represent an important innovation in medicine, providing new treatment options for patients with serious diseases. With the continuous development of technology and the accumulation of clinical practice, universal cell therapy will continue to play an important role in the medical field.
Key Features:
The research report on the Universal Cell Therapy Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Universal Cell Therapy Drug market.
Market Overview: The report provides a comprehensive overview of the Universal Cell Therapy Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Cell Therapy, Gene Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Universal Cell Therapy Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Universal Cell Therapy Drug market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Universal Cell Therapy Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Universal Cell Therapy Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Universal Cell Therapy Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Universal Cell Therapy Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Universal Cell Therapy Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Universal Cell Therapy Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Universal Cell Therapy Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Cell Therapy
Gene Therapy
Stem Cell Therapy
Market segment by Application
Hospital
Research Center
Global Universal Cell Therapy Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Novartis
Gilead Sciences
Bluebird Bio
Juno Therapeutics
Spark Therapeutics
Kite Pharma
Celgene
Regeneron Pharmaceuticals
Adaptimmune
CRISPR Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Universal Cell Therapy Drug, market overview.
Chapter 2: Global Universal Cell Therapy Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Universal Cell Therapy Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Universal Cell Therapy Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Universal Cell Therapy Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Universal Cell Therapy Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Universal Cell Therapy Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Universal Cell Therapy Drug Overall Market Size
2.1 Global Universal Cell Therapy Drug Market Size: 2022 VS 2029
2.2 Global Universal Cell Therapy Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Universal Cell Therapy Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Universal Cell Therapy Drug Players in Global Market
3.2 Top Global Universal Cell Therapy Drug Companies Ranked by Revenue
3.3 Global Universal Cell Therapy Drug Revenue by Companies
3.4 Global Universal Cell Therapy Drug Sales by Companies
3.5 Global Universal Cell Therapy Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Universal Cell Therapy Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Universal Cell Therapy Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Universal Cell Therapy Drug Players in Global Market
3.8.1 List of Global Tier 1 Universal Cell Therapy Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Universal Cell Therapy Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Universal Cell Therapy Drug Market Size Markets, 2022 & 2029
4.1.2 Cell Therapy
4.1.3 Gene Therapy
4.1.4 Stem Cell Therapy
4.2 By Type – Global Universal Cell Therapy Drug Revenue & Forecasts
4.2.1 By Type – Global Universal Cell Therapy Drug Revenue, 2018-2023
4.2.2 By Type – Global Universal Cell Therapy Drug Revenue, 2024-2029
4.2.3 By Type – Global Universal Cell Therapy Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Universal Cell Therapy Drug Sales & Forecasts
4.3.1 By Type – Global Universal Cell Therapy Drug Sales, 2018-2023
4.3.2 By Type – Global Universal Cell Therapy Drug Sales, 2024-2029
4.3.3 By Type – Global Universal Cell Therapy Drug Sales Market Share, 2018-2029
4.4 By Type – Global Universal Cell Therapy Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Universal Cell Therapy Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Research Center
5.2 By Application – Global Universal Cell Therapy Drug Revenue & Forecasts
5.2.1 By Application – Global Universal Cell Therapy Drug Revenue, 2018-2023
5.2.2 By Application – Global Universal Cell Therapy Drug Revenue, 2024-2029
5.2.3 By Application – Global Universal Cell Therapy Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Universal Cell Therapy Drug Sales & Forecasts
5.3.1 By Application – Global Universal Cell Therapy Drug Sales, 2018-2023
5.3.2 By Application – Global Universal Cell Therapy Drug Sales, 2024-2029
5.3.3 By Application – Global Universal Cell Therapy Drug Sales Market Share, 2018-2029
5.4 By Application – Global Universal Cell Therapy Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Universal Cell Therapy Drug Market Size, 2022 & 2029
6.2 By Region – Global Universal Cell Therapy Drug Revenue & Forecasts
6.2.1 By Region – Global Universal Cell Therapy Drug Revenue, 2018-2023
6.2.2 By Region – Global Universal Cell Therapy Drug Revenue, 2024-2029
6.2.3 By Region – Global Universal Cell Therapy Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Universal Cell Therapy Drug Sales & Forecasts
6.3.1 By Region – Global Universal Cell Therapy Drug Sales, 2018-2023
6.3.2 By Region – Global Universal Cell Therapy Drug Sales, 2024-2029
6.3.3 By Region – Global Universal Cell Therapy Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Universal Cell Therapy Drug Revenue, 2018-2029
6.4.2 By Country – North America Universal Cell Therapy Drug Sales, 2018-2029
6.4.3 US Universal Cell Therapy Drug Market Size, 2018-2029
6.4.4 Canada Universal Cell Therapy Drug Market Size, 2018-2029
6.4.5 Mexico Universal Cell Therapy Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Universal Cell Therapy Drug Revenue, 2018-2029
6.5.2 By Country – Europe Universal Cell Therapy Drug Sales, 2018-2029
6.5.3 Germany Universal Cell Therapy Drug Market Size, 2018-2029
6.5.4 France Universal Cell Therapy Drug Market Size, 2018-2029
6.5.5 U.K. Universal Cell Therapy Drug Market Size, 2018-2029
6.5.6 Italy Universal Cell Therapy Drug Market Size, 2018-2029
6.5.7 Russia Universal Cell Therapy Drug Market Size, 2018-2029
6.5.8 Nordic Countries Universal Cell Therapy Drug Market Size, 2018-2029
6.5.9 Benelux Universal Cell Therapy Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Universal Cell Therapy Drug Revenue, 2018-2029
6.6.2 By Region – Asia Universal Cell Therapy Drug Sales, 2018-2029
6.6.3 China Universal Cell Therapy Drug Market Size, 2018-2029
6.6.4 Japan Universal Cell Therapy Drug Market Size, 2018-2029
6.6.5 South Korea Universal Cell Therapy Drug Market Size, 2018-2029
6.6.6 Southeast Asia Universal Cell Therapy Drug Market Size, 2018-2029
6.6.7 India Universal Cell Therapy Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Universal Cell Therapy Drug Revenue, 2018-2029
6.7.2 By Country – South America Universal Cell Therapy Drug Sales, 2018-2029
6.7.3 Brazil Universal Cell Therapy Drug Market Size, 2018-2029
6.7.4 Argentina Universal Cell Therapy Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Universal Cell Therapy Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Universal Cell Therapy Drug Sales, 2018-2029
6.8.3 Turkey Universal Cell Therapy Drug Market Size, 2018-2029
6.8.4 Israel Universal Cell Therapy Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Universal Cell Therapy Drug Market Size, 2018-2029
6.8.6 UAE Universal Cell Therapy Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Universal Cell Therapy Drug Major Product Offerings
7.1.4 Novartis Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Universal Cell Therapy Drug Major Product Offerings
7.2.4 Gilead Sciences Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Bluebird Bio
7.3.1 Bluebird Bio Company Summary
7.3.2 Bluebird Bio Business Overview
7.3.3 Bluebird Bio Universal Cell Therapy Drug Major Product Offerings
7.3.4 Bluebird Bio Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.3.5 Bluebird Bio Key News & Latest Developments
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Company Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics Universal Cell Therapy Drug Major Product Offerings
7.4.4 Juno Therapeutics Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.4.5 Juno Therapeutics Key News & Latest Developments
7.5 Spark Therapeutics
7.5.1 Spark Therapeutics Company Summary
7.5.2 Spark Therapeutics Business Overview
7.5.3 Spark Therapeutics Universal Cell Therapy Drug Major Product Offerings
7.5.4 Spark Therapeutics Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.5.5 Spark Therapeutics Key News & Latest Developments
7.6 Kite Pharma
7.6.1 Kite Pharma Company Summary
7.6.2 Kite Pharma Business Overview
7.6.3 Kite Pharma Universal Cell Therapy Drug Major Product Offerings
7.6.4 Kite Pharma Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.6.5 Kite Pharma Key News & Latest Developments
7.7 Celgene
7.7.1 Celgene Company Summary
7.7.2 Celgene Business Overview
7.7.3 Celgene Universal Cell Therapy Drug Major Product Offerings
7.7.4 Celgene Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.7.5 Celgene Key News & Latest Developments
7.8 Regeneron Pharmaceuticals
7.8.1 Regeneron Pharmaceuticals Company Summary
7.8.2 Regeneron Pharmaceuticals Business Overview
7.8.3 Regeneron Pharmaceuticals Universal Cell Therapy Drug Major Product Offerings
7.8.4 Regeneron Pharmaceuticals Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.8.5 Regeneron Pharmaceuticals Key News & Latest Developments
7.9 Adaptimmune
7.9.1 Adaptimmune Company Summary
7.9.2 Adaptimmune Business Overview
7.9.3 Adaptimmune Universal Cell Therapy Drug Major Product Offerings
7.9.4 Adaptimmune Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.9.5 Adaptimmune Key News & Latest Developments
7.10 CRISPR Therapeutics
7.10.1 CRISPR Therapeutics Company Summary
7.10.2 CRISPR Therapeutics Business Overview
7.10.3 CRISPR Therapeutics Universal Cell Therapy Drug Major Product Offerings
7.10.4 CRISPR Therapeutics Universal Cell Therapy Drug Sales and Revenue in Global (2018-2023)
7.10.5 CRISPR Therapeutics Key News & Latest Developments
8 Global Universal Cell Therapy Drug Production Capacity, Analysis
8.1 Global Universal Cell Therapy Drug Production Capacity, 2018-2029
8.2 Universal Cell Therapy Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Universal Cell Therapy Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Universal Cell Therapy Drug Supply Chain Analysis
10.1 Universal Cell Therapy Drug Industry Value Chain
10.2 Universal Cell Therapy Drug Upstream Market
10.3 Universal Cell Therapy Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Universal Cell Therapy Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer